Leprosy is a chronic infectious disease which has affected mankind for more than 4,000 years[@b1]. Although the number of new cases of leprosy globally decreased to 213,899 patients in 2014[@b2], the disease is still a significant threat to public health in many parts of the world. The pathogen, *Mycobacterium leprae (M. leprae*), is an obligate intracellular parasite and primarily affects the skin and peripheral nerves[@b3]. When compared against its close relative, *M. tuberculosis*, the genome of *M. leprae* shows an extremely eroded evolution, which has led to nearly half of the functional genes (especially in the metabolic pathways) undergoing inactivation or pseudogenation[@b4][@b5][@b6]. This marked reduction in the number of working genes might be the primary reason why *M. leprae* has a long half-life *in vivo* and cannot be cultured *in vitro*. As a result, the provision of energy metabolites and nutritional products by the host has become essential to the survival of *M. leprae*.

Mitochondria are crucial organelles involved in the cellular energy supply, regulation of apoptotic signals and autophagy, and defenses against pathogenic microbe invasion[@b7][@b8][@b9]. Recent studies showed that the host mitochondria might play important roles in *M. leprae* infection. A lower expression of several mitochondrial genes was observed in nerve biopsies from leprosy patients compared to non-leprous individuals using a microarray assay[@b10]. We also found a significantly increased mtDNA copy number in lepromatous leprosy patients[@b11] compared with controls. The mitochondrial outer membrane protein, LRRK2, has been identified by a genome-wide association study (GWAS) as one of the leprosy susceptibility genes in Han Chinese population[@b12], and this was confirmed by our recent case-control study[@b13] and other studies[@b14][@b15], although the associated *LRRK2* SNPs or their effects were different in these studies. Most recently, we provided solid evidence to show that the *OPA1* gene, encoding an mitochondrial inner membrane protein, was associated with leprosy susceptibility possibly by affecting mitochondrial function and antimicrobial pathways[@b16]. All these lines of evidence support our previous hypothesis that mitochondrial function may affect host susceptibility to *M. leprae* and the onset of clinical leprosy[@b11].

The *presenilins-associated rhomboid-like (PARL)* gene is located on chromosome 3q27 and consists of ten exons. PARL is a mitochondrial membrane protein and is a key regulator of mitochondrial integrity and function, such as mitochondrial morphology, apoptosis and glucose metabolism[@b17][@b18][@b19]. PARL can interact with OPA1 during apoptosis by regulating apoptotic cristae remodeling and cytochrome c release[@b20]. Moreover, PARL together with OPA1 can control mitochondrial morphology[@b19] and participate in mitochondrial adaptation to heat shock[@b21]. Genetic variants in the *PARL* gene can influence mitochondrial content[@b22] and susceptibility to Parkinson's disease[@b23], type 2 diabetes[@b24] and LHON[@b25], although there were some negative reports[@b26][@b27].

The PTEN induced putative kinase 1 (PINK1) is a serine/threonine kinase protein that is localized in mitochondria[@b28]. PINK1 knockout mice had mitochondrial dysfunction and increased sensitivity to oxidative stress[@b29]. Moreover, PINK1 could phosphorylate Parkin, leading to the activation of E3 ligase and the NF-κB signaling pathway[@b30]. The cleavage of PINK1 was mediated by PARL and this was affected by mitochondrial membrane potential[@b31]. This scenario negatively regulated the PINK1- and PARK2/Parkin-dependent mitophagy[@b32]. Mutations in *PINK1* have been reported to be associated with Parkinson's disease[@b28][@b33] and schizophrenia[@b34], but there was a controversy[@b27].

In this study, we aimed to investigate the possible association of genetic variants in the *PARL* and *PINK1* genes with leprosy in Han Chinese. Our results provided several lines of evidence showing that *PARL* and *PINK1* confer genetic susceptibility to leprosy.

Results
=======

Association of *PARL* and *PINK1* SNPs with leprosy *per se* and multibacillary patients
----------------------------------------------------------------------------------------

The minor allele frequencies (MAF) of the SNPs analyzed in this study ranged from 5.8% to 48.4% ([Table 1](#t1){ref-type="table"}). The power to detect an odds ratio (OR) value as 1.6 for risk allele was expected to be above 77.0% ([Fig. S1](#S1){ref-type="supplementary-material"}). SNPs rs10937153, rs1573132 and rs607254 were not in Hardy-Weinberg equilibrium in controls ([Table S1](#S1){ref-type="supplementary-material"}, *P* \< 0.05) and were excluded in the following analyses. The allele and genotype frequencies of the 10 SNPs in 527 leprosy patients, 583 healthy subjects from the Yuxi Prefecture, Yunnan Province, and pooled 3093 leprosy-unaffected controls were listed in [Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"}. We constructed the linkage disequilibrium (LD) map of all the tested SNPs in the Yuxi leprosy cases, Yuxi controls and pooled leprosy-unaffected controls ([Fig. 1](#f1){ref-type="fig"}), and observed similar LD structures for these populations. We further performed the principal component (PC) analysis for the studied populations based on the observed genotype frequencies of the 10 SNPs, together with data of the CHB, CHD, JPT, CEU populations from the HapMap data set[@b35]. The Yuxi leprosy patient, Yuxi controls and the reported controls from Hunan Province and Shanghai were clustered together, suggesting no substantial population substructure between the cases and controls ([Fig. S2](#S1){ref-type="supplementary-material"}).

The RegulomeDB database was used to annotate the analyzed SNPs[@b36]. Except for rs2305666 and rs1043424, the other SNPs showed a signal as DNase I hypersensitivity site. SNPs rs10916840 and rs4704 were located in transcription factor binding sites, and rs1061593 showed an eQTL effect ([Table 1](#t1){ref-type="table"}). Two *PARL* SNPs showed an association with leprosy *per se* (rs12631031-A allele, OR = 1.189, 95% CI \[1.029--1.381\], *P* = 0.019; rs12631031, *P* ~dominant~ = 0.033; rs7653061, *P* ~dominant~ = 0.027) and MB (rs12631031-A allele, OR = 1.251, 95% CI \[1.036--1.510\], *P* = 0.020; rs12631031, *P* ~dominant~ = 0.019; rs7653061, *P* ~dominant~ = 0.023) when compared with healthy control population from the same region or with the pooled control populations ([Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"}). One *PINK1* SNP (rs4704) showed an association with leprosy *per se* when compared with healthy control population from the Yuxi area (*P*~dominant~ = 0.033), and the association survived (TT vs. TC vs. CC, *P*~genotypic~ = 0.004; *P*~dominant~ = 0.027) when we compared the patients with the pooled controls ([Table 2](#t2){ref-type="table"}).

Haplotypes were reconstructed for four *PARL* SNPs (rs1061593-rs2305666-rs12631031-rs7653061) and four *PINK1* SNPs (rs10916832-rs10916840-rs1043424-rs4704; SNPs rs650616 and rs3738140 were excluded because these two SNPs were not genotyped in the pooled populations). There were no associations of *PARL* haplotypes or *PINK1* haplotypes with leprosy (cases versus pooled control samples, global *P-*value \> 0.05). We observed no significant difference of haplotype distribution frequencies between the cases and controls ([Table S2](#S1){ref-type="supplementary-material"}).

Deep sequencing of *PARL* and *PINK1* exons identified an association of coding variants with leprosy
-----------------------------------------------------------------------------------------------------

To identify whether there are any other rare (allele frequency \< 1%) or common variants that would confer risk to leprosy, we performed targeted gene sequencing (including the flanking region of the gene) for *PARL, PINK1* and *PARK2* in 80 leprosy patients from the Wenshan Prefecture, Yunnan Province, and compared to the CHB data in 1000 Genomes dataset[@b37]. Although we did not find any rare variants of *PARL* and *PINK1* to be associated with leprosy (*P *\> 0.05; partially due to the small sample size), one missense variant (rs3732581 \[p.V212L\], *P* = 6.434 × 10^−5^) and one synonymous variant (rs13091 \[p.H216\], *P* = 1.058 × 10^−4^) in *PARL* and one synonymous variant (rs45530340, \[p.L63\], *P* = 2.668 × 10^−4^) in *PINK1* were significantly associated with leprosy *per se* ([Table S3](#S1){ref-type="supplementary-material"}). It should be mentioned that the comparison might be biased as we compared the Wenshan sample to the CHB sample (103 Han Chinese from Beijing) from the 1000 Genomes dataset[@b37] and the samples were not geographically matched. Further *in silico* program affiliated predication analysis showed that no missense variants in *PARL, PINK1* and *PARK2* were predicted to be pathogenic ([Table S3](#S1){ref-type="supplementary-material"}).

The risk SNPs affected leprosy-related gene expression in human tissues
-----------------------------------------------------------------------

We tested the expression quantitative trait loci (eQTLs) of 34 SNPs (including 5 index tag SNPs and 21 captured *PARL* SNPs from the HapMap database[@b35], and 8 tag SNPs in *PINK1*) in leprosy-related human blood, skin and nerve tissues from the Genotype-Tissue Expression project (GTEx, http:// [www.gtexportal.org/](http://www.gtexportal.org/) home/[@b38]). We found that 18 of 26 *PARL* SNPs were significant *cis* eQTLs in whole blood (*P *\< 1.0 × 10^−4^). Among them, 10 of 26 SNPs were remarkably significant (*P *\< 1.0 × 10^−8^). Notably, SNP rs7644746 that was tagged by the risk SNP rs7653061 reached a *P* value of 5.6 × 10^−24^ in blood ([Fig. 2a](#f2){ref-type="fig"}). *PINK1* SNP rs10916840 was a *cis* eQTL in skin tissue (1.5 × 10^−9^) based on the GTEx dataset[@b38], whereas rs4704 was a significant *trans* eQTL in whole blood (3.1 × 10^−30^; [Fig. 2b](#f2){ref-type="fig"}). Both SNPs affected the *PINK1* mRNA expression level.

The specific expression pattern of *PARL* and *PINK1* were checked in a variety of human tissues from the BioGPS[@b39] (<http://biogps.org/#goto=welcome>; [Figures S3 and S4](#S1){ref-type="supplementary-material"}). We noticed that *PARL* mRNA expression level was extremely high in immune cells, but *PINK1* had an extremely high mRNA expression in central nervous system. We observed a significantly differential mRNA expression of *PINK1*, but not *PARL*, in leprosy skin lesions of 66 patients from the Gene Expression Omnibus dataset (GEO; <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74481>)[@b40] ([Table S4](#S1){ref-type="supplementary-material"}).

Protein interaction network analysis showed an active interaction of PARL with leprosy risk genes
-------------------------------------------------------------------------------------------------

To evaluate the protein interaction with PARL and PINK1, we used the GeneMANIA prediction server[@b41] and identified that PARL could physically interacted and co-expressed with PINK1. PARL and PINK1 could directly or indirectly interact with many proteins, such as FXR1, NDUFB5, TRAP1 and PARK2 ([Fig. 3](#f3){ref-type="fig"}). Note that PINK1 directly interacted with PARK2, which was identified as a leprosy risk gene in several populations[@b42][@b43][@b44]. However, our NGS analysis for the *PARK2* gene revealed no association of this gene with leprosy though we observed positive associations between *PARL* and leprosy or between *PINK1* and leprosy in this relatively small sample. This observation was consistent with a previous report for no association of *PARK2* SNPs with leprosy in Han Chinese population[@b45]. However, it should be noted that our exon sequencing of the *PARK2* gene did not cover its promoter region, and we could not exclude a possibility that there existed leprosy-associated SNP(s).

To discern whether PARL and PINK1 participated in molecular networks that contain proteins encoded by leprosy susceptibility genes, we constructed the protein interaction network of PARL, PINK1 and the reported 228 leprosy-associated genes ([Table S5](#S1){ref-type="supplementary-material"}; ref. [@b46] and references therein) by the GeneMANIA[@b41]. We found that PARL and PINK1 could physically interacted, co-expressed and genetically interacted with those proteins of the reported leprosy susceptibility genes, such as *OPA1, PARK2, HLA-A, HLA-DRA, HLA-DQB*, and *IL10RA* (ref. [@b46] and references therein) ([Figure S5](#S1){ref-type="supplementary-material"}).

Discussion
==========

Leprosy is a complex infectious and neurological disease, with impairment of both the immune and peripheral nerve systems during the infection[@b3]. Host genetic background would affect the susceptibility to leprosy, because of the genomic decay of *M. leprae*, and its completely parasitic mode. Genetic studies, especially recent GWAS in Han Chinese[@b12], have suggested an important role for host genetic effect on leprosy susceptibility, although the exact mechanism was still unknown[@b47][@b48]. Mitochondria play important roles in cellular energy supply, cell signaling, mitophagy and anti-microbe immune responses[@b7][@b8][@b9]. It is therefore reasonable to believe that genes involved in mitochondrial function would affect the host response to microbe infection. Indeed, we recently provided evidence that genetic variants of the mitochondrial genes, like *LRRK2* and *OPA1* were associated with leprosy[@b13][@b16], although three mitochondrial-related antimicrobial/antiviral immune genes (*MAVS, MITA* and *MFN2*) showed no evidence to be associated with leprosy[@b49]. In this study, we found that two mitochondrial genes, *PARL* and *PINK1*, conferred genetic susceptibility to leprosy *per se* and/or multibacillary leprosy.

Among the analyzed tag SNPs in the *PARL* and *PINK1* genes, three SNPs (rs12631031 and rs7653061 of *PARL*; rs4704 of *PINK1*) were associated with leprosy *per se* and/or MB. Furthermore, deep sequencing of the *PARL, PINK1* and *PARK2* genes in a relatively small sample identified two *PARL* variants (rs3732581 \[p.V212L\], rs13091 \[p.H216\]) and one *PINK1* variant (rs45530340, \[p.L63\]) that were associated with leprosy. We found no variant in the coding region of the *PARK2* gene to be linked with leprosy. There is a possibility that promoter variant in this gene might confer risk to leprosy and this awaits future study, as the promoter region was not covered by the current exon sequencing. It was well known that genetic variation could influence gene expression[@b50][@b51], therefore we performed eQTL analysis to elucidate whether these leprosy risk variants altered the *PARL* and *PINK1* mRNA expression. We observed that two risk SNPs of *PARL* and all their captured SNPs were *cis* eQTLs for *PARL* mRNA expression in human blood (*P* value from 5.6 × 10^−5^ to 5.6 × 10^−24^), and two risk SNPs of *PINK1* were *cis* and *trans* eQTLs for *PINK1* mRNA expression in skin (*P* = 1.5 × 10^−9^) and blood (*P* = 3.1 × 10^−30^), respectively. Nevertheless, we only found a significantly different expression of *PINK1* mRNA, but not *PARL* mRNA, between leprotic lesions (leprosy *per se* or its subtypes) and control tissues based on the re-analysis of reported datasets[@b10][@b40]. The exact reason for the discrepancy of *PARL* mRNA expression remains unknown and awaits future study.

In our recent studies, we identified an association of two mitochondrial genes (*LRRK2* and *OPA1*) with leprosy[@b13][@b16]. Although there was no positive interaction among *PARL, PINK1, OPA1* and *LRRK2* SNPs ([Table S6](#S1){ref-type="supplementary-material"}) based on our recently reported data[@b13][@b16] and current data, the positive associations of these four genes with leprosy suggested that mitochondrial related genes should play active roles in leprosy. The protein interaction network analysis supported this speculation, as we found that the other mitochondrial genes (*MCCD1, SDHD, SNCA*, and *VARS2*) could interact with the reported leprosy susceptibility genes ([Table S5](#S1){ref-type="supplementary-material"}). Whether these genes play their roles by directly affecting mitochondrial function, or by participating in other signaling pathways, and then affect leprosy susceptibility, is still an open question.

This study had two limitations. First, the Wenshan population analyzed by the NGS was relatively small, and we compared this population to the CHB data in 1000 Genomes dataset[@b37], which might lead to a biased result as the samples were not well matched. For the Yuxi sample, the coverage of common *PARL* and *PINK1* SNPs might not be sufficient. Second, we did not perform functional assays to characterize the role of *PARL, PINK1* and their interactions with previously reported mitochondrial risk genes such as *OPA1*[@b16] and *LRRK2*[@b13] during *M. leprae* infection.

In summary, we found that common variants of the mitochondrial genes *PARL* and *PINK1* would confer risk to leprosy *per se* and/or MB. Combining the reported results[@b13][@b16][@b46] and the protein interaction network analysis, we found that *PARL* and *PINK1* were participated in a highly connected network formed by the reported leprosy risk genes (ref. [@b46] and references therein). Future studies are needed to validate the association in independent populations and to explore the underlying mechanism during leprosy onset and progression.

Materials and Methods
=====================

Study subjects
--------------

This study was carried out in 1,110 individuals from the Yuxi Prefecture, Yunnan Province: 527 individuals were leprosy patients (onset age from 2 to 67 years, mean age: 24.7 ± 12.3 years; male/female ratio = 387/140; multibacillary/paucibacillary = 279/ 248); 583 individuals were healthy control subjects from the same geographic area (age from 4 to 88 years, mean age: 36.0 ± 15.5 years; male/female ratio = 365/ 218). These samples had been analyzed for potential associations of other genes with leprosy in our previous studies[@b13][@b52]. A total of 80 unrelated leprosy patients (38 lepromatous leprosy \[LL\] patients and 42 tuberculoid leprosy \[TT\] patients) with a family history of disease (each family has at least two leprosy patients) were collected from the Wenshan Prefecture, Yunnan Province. In brief, the diagnosis of leprosy patients was based on clinical and histopathological features, as well as the bacteriological index if available. A total of 2,510 unaffected Han Chinese from South China (including 504 schizophrenia cases and 480 healthy controls from Hunan Province and 624 schizophrenia cases and 902 healthy controls from Shanghai) that were analyzed for 5 *PARL* SNPs and 4 *PINK1* SNPs in our recent study[@b27] were included in this study for comparison, as we found no association between *PARL* and *PINK1* variants and schizophrenia in these sample groups[@b27]. All healthy individuals and the reported schizophrenia patients had no history of leprosy, HIV infection, and tuberculosis. Written informed consents conforming to the tenets of the Declaration of Helsinki were obtained from each participant or the appointed guardians of the patients (for those who were unable to provide informed consent at the time of blood collection) prior to the study. The experimental methods were carried out in accordance with the approved guidelines. The institutional review board of the Kunming Institute of Zoology (KIZ) approved all experimental protocols of this study.

SNP selection, genotyping and NGS
---------------------------------

Genomic DNA was extracted from whole blood by using the AxyPrep™ Blood Genomic DNA Miniprep Kit (Axygen, USA). We selected five *PARL* tag SNPs (rs1061593, rs2305666, rs10937153, rs12631031, rs7653061; [Figure S6](#S1){ref-type="supplementary-material"}) and eight *PINK1* tag SNPs (rs10916832, rs10916840, rs1043424, rs1573132, rs650616, rs607254, rs3738140, rs4704; [Figure S7](#S1){ref-type="supplementary-material"}) that were located in a region spanning *PINK1* to *DDOST* based on the linkage disequilibrium (LD) pattern of the analyzed genes using the international HapMap project data set ([www.hapmap.ncbi.nlm.nih.gov/](http://www.hapmap.ncbi.nlm.nih.gov/), Phase 3, CHB[@b35]). The potential roles of SNPs, e.g. affecting transcription factor binding sites or enacting other regulatory factor / mechanism, were estimated by referring to the RegulomeDB dataset (<http://www.regulomedb.org/>)[@b36]. All SNPs were genotyped in the cases and controls from the Yuxi Prefecture by using the SNaPshot assay ([Table S7](#S1){ref-type="supplementary-material"}) as described in our previous studies[@b27][@b52] at the Kunming Biological Diversity Regional Center of Instruments, KIZ. For the NGS of the *PARL, PINK1* and *PARK2* genes in 80 leprosy patients from the Wenshan Prefecture, we used the same approach as described in our recent study[@b53].

PC analysis, expression and expression quantitative trait loci (eQTL) analysis
------------------------------------------------------------------------------

PC analysis was performed using the genotype frequencies of 10 tag SNPs (three SNPs were excluded due to the deviation of the Hardy-Weinberg equilibrium \[HWE\]) to show the overall clustering pattern of the 8 populations (leprosy and control populations from the Yuxi Prefecture of Yunnan Province, unaffected Han Chinese populations from Hunan Province and Shanghai[@b27], CHB \[136 Han Chinese in Beijing\], CHD \[109 Chinese in Metropolitan Denver, Colorado\], JPT \[113 Japanese in Tokyo, Japan\], and CEU \[113 Utah residents with Northern and Western European ancestry\] populations from the HapMap database[@b35]) by using the POPSTR software (<http://harpending.humanevo.utah.edu/popstr/>).

We performed eQTL analysis in different human tissues by using two publically available expression data sets[@b10][@b40]. We first investigated whether the *PARL* and *PINK1* variants affect gene expression in human whole blood, brain and skin tissues using the Genotype-Tissue Expression project (GTEx, <http://www.gtexportal.org/home/>[@b38]) data and the HaploReg dataset (<http://www.broadinstitute.org/mammals/haploreg/haploreg.php>)[@b54]. We also considered the overall expression profiling of these two genes in the BioGPS database (<http://biogps.org/#goto=welcome>)[@b39].

We reanalyzed the largest microarray data regarding leprosy skin lesions, including 24 MB (10 mid-borderline leprosy \[BB\] + 10 borderline lepromatous \[BL\] + 4 lepromatous \[LL\]), 20 PB (10 tuberculoid \[TT\] + 10 borderline-tuberculoid \[BT\]), 14 type I reaction (R1), and 10 type II reaction (R2) patients, and normal skin biopsies from 9 healthy individuals. The data was retrieved from GEO under accession series GSE74481 (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74481>)[@b40].

Protein interaction network analysis
------------------------------------

To construct the potential protein interaction network of PARL and PINK1, and to test whether the *PARL* and *PINK1* genes interact with the other leprosy risk genes as compiled in our recent study (ref. [@b46] and references therein), we performed interaction network analysis by referring to a high-confidence protein interaction database GeneMANIA (<http://www.genemania.org/>)[@b41].

Statistical analysis
--------------------

The genotyping call rate of each tag SNP was above 98.7% in our subjects. Cases and controls were compared on the basis of the frequencies of genotypes and alleles. We randomly selected about 2% of samples for direct sequencing and confirmed 100% of consistence with the SNaPshot genotyping results. Power calculations were performed using Quanto software[@b55]. Linkage disequilibrium (LD) structure was determined using Haploview 4.2 [@b56]. Deviation from the HWE, haplotype comparison and SNP-SNP interaction were performed by using PLINK v1.07 [@b57]. The significant SNPs were further calculated by using the logistic regression, with an adjustment for sex. We predicted the potential pathogenicity of variants in the *PARL, PINK1* and *PARK2* genes identified by the NGS by using an *in silico* program affiliated prediction, following the procedure described in our recent study (ref. [@b53] and references therein). A *P* value \< 0.05 was considered to be statistically significant.
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![eQTL analysis of the *PARL* and *PINK1* genes.\
*cis* and *trans* eQTL of the *PARL* and *PINK1* tag SNPs in human blood, skin and nerve tissues were identified by using the GTEx (<http://www.gtexportal.org/home>)[@b38] and HaploReg dataset (<http://www.broadinstitute.org/mammals/haploreg/haploreg.php>)[@b54].](srep37086-f2){#f2}

![Protein interaction network of the *PARL* and *PINK1* genes.\
PARL can directly interact with PINK1 according to the GeneMANIA database (<http://genemania.org/>)[@b41]. The minimum required interaction score is \>0.7 and the line thickness indicates the strength of data support.](srep37086-f3){#f3}

###### Allele frequencies of 4 *PARL* SNPs and 6 *PINK1* SNPs in 527 leprosy patients and 583 healthy controls from the Yuxi Prefecture of Yunnan Province, and in 3093 pooled Han Chinese across China.

  SNP ID        Population\*   Allele   MAF (control)   Leprosy *per se*      MB               PB            RegulomeDB Score^a^                                                                          
  ------------ -------------- -------- --------------- ------------------ ----------- --------------------- --------------------- ----------- --------------------- ------- ------- --------------------- -----
  rs1061593         Yuxi        A/G         0.478            0.484           0.777     1.024 (0.867-1.211)          0.477            0.966     0.996 (0.813-1.219)   0.492   0.601   1.058 (0.856-1.307)  1 f
                   Pooled                   0.479                            0.801     1.017 (0.892-1.160)                           0.896     0.988 (0.831-1.176)           0.601   1.050 (0.874-1.263)   
  rs2305666         Yuxi        C/A         0.388            0.384           0.840     0.982 (0.827-1.167)          0.376            0.619     0.948 (0.770-1.169)   0.393   0.839   1.023 (0.822-1.272)  6
                   Pooled                   0.402                            0.277     0.928 (0.810-1.062)                           0.228     0.896 (0.749-1.072)           0.721   0.966 (0.798-1.169)   
  rs12631031        Yuxi        A/G         0.299            0.303           0.814     1.022 (0.852-1.226)          0.314            0.522     1.074 (0.863-1.336)   0.291   0.761   0.965 (0.765-1.217)  5
                   Pooled                   0.267                          **0.019**   1.189 (1.029-1.381)                         **0.020**   1.251 (1.036-1.510)           0.252   1.126 (0.919-1.380)   
  rs7653061         Yuxi        G/T         0.484            0.467           0.444     0.937 (0.793-1.107)          0.473            0.678     0.958 (0.783-1.173)   0.461   0.400   0.913 (0.739-1.129)  5
                   Pooled                   0.442                            0.121     1.110 (0.973-1.266)                           0.153     1.135 (0.954-1.351)           0.405   1.082 (0.899-1.302)   
  rs10916832        Yuxi        C/T         0.342            0.349           0.750     1.029 (0.862-1.230)          0.362            0.422     1.091 (0.882-1.350)   0.333   0.734   0.962 (0.767-1.205)  5
                   Pooled                   0.34                             0.560     1.042 (0.908-1.196)                           0.281     1.104 (0.922-1.323)           0.785   0.973 (0.800-1.184)   
  rs10916840        Yuxi        A/G         0.270            0.281           0.558     1.059 (0.874-1.284)          0.281            0.623     1.060 (0.840-1.337)   0.281   0.645   1.058 (0.831-1.348)  4
                   Pooled                   0.265                            0.301     1.082 (0.932-1.256)                           0.431     1.083 (0.888-1.319)           0.465   1.081 (0.877-1.333)   
  rs1043424         Yuxi        C/A         0.363            0.357           0.783     0.976 (0.818-1.164)          0.362            0.961     0.995 (0.805-1.230)   0.352   0.677   0.954 (0.763-1.192)  7
                   Pooled                   0.375                            0.279     0.927 (0.809-1.063)                           0.543     0.946 (0.789-1.133)           0.319   0.907 (0.747-1.100)   
  rs650616          Yuxi        A/G         0.437            0.468           0.149     1.133 (0.956-1.344)          0.457            0.427     1.087 (0.885-1.333)   0.480   0.112   1.189 (0.960-1.473)  5
  rs3738140         Yuxi        A/G         0.067            0.058           0.380     0.856 (0.605-1.211)          0.052            0.225     0.763 (0.491-1.183)   0.065   0.864   0.963 (0.629-1.476)  5
  rs4704            Yuxi        T/C         0.372            0.388           0.455     1.069 (0.898-1.273)          0.393            0.418     1.090 (0.885-1.344)   0.382   0.700   1.044 (0.838-1.302)  4
                   Pooled                   0.375                            0.449     1.054 (0.921-1.206)                           0.426     1.075 (0.900-1.284)           0.766   1.029 (0.851-1.245)   

MB -- multibacillary leprosy; PB -- paucibacillary leprosy; *P* - *P* value; OR -- Odds Ratio; 95% CI -- 95% confidence interval; MAF -- minor allele frequency.

^\*^Pooled - Pooled Han Chinese without leprosy, which contained the reported samples from Hunan Province (N = 984), Shanghai (N = 1526)[@b27], and the Yuxi control samples in this study (Yuxi).

^\#^*P* values \< 0.05 were marked in bold and were recalculated by using the unconditional logistic regression, with an adjustment for sex.

^a^The RegulomeDB score was taken from <http://www.regulomedb.org/>:[@b36] 1 f, eQTL + TF binding/DNase peak; 4, TF binding + DNase peak; 5, TF binding or DNase peak; 6, other; 7, No data.

###### Comparison of the genotype frequencies of 4 *PARL* SNPs and 6 *PINK1* SNPs in 527 leprosy patients and 583 healthy controls from the Yuxi Prefecture of Yunnan Province, and in 3093 pooled unaffected Han Chinese.

  SNP ID             Test model             No. of controls^\*^       Leprosy *per se* vs. Controls    MB vs. Controls     PB vs. Controls                                    
  ------------ ----------------------- ----------------------------- ------------------------------- -------------------- ----------------- -------------------- ------------ ----------------
  rs1061593     GENO (Yuxi \| pooled)   132/293/158 \| 703/1542/829            123/259/140              0.936 \| 0.940        61/143/74        0.947 \| 0.909     62/116/66    0.664 \| 0.624
  AA/GA/GG      DOM (Yuxi \| pooled)       425/158 \| 2948/3200                  382/140                0.916 \| 0.943         204/74          0.881 \| 0.900       178/66     0.988 \| 0.978
                REC (Yuxi \| pooled)        132/451 \| 2245/829                  123/399                0.717 \| 0.727         61/217          0.818 \| 0.724       62/182     0.392 \| 0.365
  rs2305666     GENO (Yuxi \| pooled)   86/278/216 \| 494/1478/1098            70/256/190               0.788 \| 0.345       35/138/104        0.677 \| 0.318     35/118/86    0.928 \| 0.834
  CC/CA/AA      DOM (Yuxi \| pooled)       364/216 \| 1972/1098                  326/190                0.886 \| 0.644         173/104         0.932 \| 0.554       153/86     0.734 \| 0.946
                REC (Yuxi \| pooled)        86/494 \| 494/2576                   70/446                 0.551 \| 0.145         35/242          0.389 \| 0.131       35/204     0.946 \| 0.557
  rs12631031    GENO (Yuxi \| pooled)   52/244/287 \| 211/1220/1643            46/225/252               0.925 \| 0.052       24/127/128        0.591 \| 0.056     22/98/124    0.901 \| 0.407
  AA/AG/GG      DOM (Yuxi \| pooled)       296/287 \| 1431/1643                  271/252              0.729 \| **0.033**       151/128       0.357 \| **0.019**    120/124     0.676 \| 0.428
                REC (Yuxi \| pooled)        52/531 \| 211/2863                   46/477                 0.942 \| 0.113         24/255          0.878 \| 0.276       22/222     0.964 \| 0.205
  rs7653061     GENO (Yuxi \| pooled)   136/292/155 \| 601/1513/960            103/282/137              0.289 \| 0.058        53/157/68        0.186 \| 0.254     50/125/69    0.657 \| 0.631
  GG/GT/TT      DOM (Yuxi \| pooled)        428/155 \| 2114/960                  385/137              0.898 \| **0.027**       210/68        0.506 \| **0.023**     175/69     0.618 \| 0.337
                REC (Yuxi \| pooled)        136/447 \| 601/2473                  103/419                0.147 \| 0.923         53/225          0.158 \| 0.845       50/194     0.373 \| 0.722
  rs10916832    GENO (Yuxi \| pooled)   66/245/240 \| 349/1367/1326            62/240/220               0.877 \| 0.825       37/128/114        0.725 \| 0.551     25/112/106   0.771 \| 0.842
  CC/CT/TT      DOM (Yuxi \| pooled)       311/240 \| 1716/1326                  302/220                0.641 \| 0.534         165/114         0.458 \| 0.379      137/106     0.987 \| 0.992
                REC (Yuxi \| pooled)        66/485 \| 349/2693                   62/460                 0.959 \| 0.789         37/242          0.596 \| 0.372       25/218     0.491 \| 0.576
  rs10916840    GENO (Yuxi \| pooled)   39/212/287 \| 212/1182/1632            32/217/251               0.413 \| 0.184       19/111/135        0.791 \| 0.635     13/106/116   0.286 \| 0.169
  AA/AG/GG      DOM (Yuxi \| pooled)       251/287 \| 1394/1632                  249/251                0.311 \| 0.121         130/135         0.522 \| 0.349      119/116     0.308 \| 0.176
                REC (Yuxi \| pooled)        39/499 \| 212/2814                   32/468                 0.588 \| 0.621         19/246          0.968 \| 0.920       13/222     0.381 \| 0.390
  rs1043424     GENO (Yuxi \| pooled)   73/253/224 \| 422/1434/1185            66/240/215               0.954 \| 0.553       39/123/116        0.883 \| 0.619     27/117/99    0.673 \| 0.475
  CC/CA/AA      DOM (Yuxi \| pooled)       326/224 \| 1856/1185                  306/215                0.858 \| 0.321         162/116         0.783 \| 0.367       144/99     0.997 \| 0.586
                REC (Yuxi \| pooled)        73/477 \| 422/2619                   66/455                 0.769 \| 0.458         39/239          0.764 \| 0.944       27/216     0.398 \| 0.227
  rs650616           GENO (Yuxi)                108/265/178                    116/257/150                  0.355             56/143/80            0.554          60/114/70        0.251
  AA/AG/GG           DOM (Yuxi)                   373/178                        373/150                    0.197              199/80              0.286            174/70         0.310
                     REC (Yuxi)                   108/443                        116/407                    0.298              56/223              0.872            60/184         0.112
  rs3738140          GENO (Yuxi)                 5/67/502                       1/59/466                      NA              1/27/251               NA            0/32/215          NA
  AA/AG/GG           DOM (Yuxi)                   72/502                         60/466                       NA               28/251                NA             32/215           NA
                     REC (Yuxi)                    5/569                          1/525                       NA                1/278                NA             0/247            NA
  rs4704        GENO (Yuxi \| pooled)   77/256/218 \| 434/1416/1192            61/282/178             **0.033 \| 0.004**      34/151/94        0.113 \| 0.053     27/131/84    0.130 \| 0.066
  TT/TC/CC      DOM (Yuxi \| pooled)       333/218 \| 1850/1192                  343/178              0.067 \| **0.027**       185/94          0.099 \| 0.071       158/84     0.195 \| 0.169
                REC (Yuxi \| pooled)        77/474 \| 434/2608                   61/460                 0.268 \| 0.119         34/245          0.475 \| 0.339       27/215     0.279 \| 0.180

MB -- multibacillary leprosy; PB -- paucibacillary leprosy; GENO: genotypic; DOM: dominant model; REC: recessive model; *P* - *P* value; OR -- Odds Ratio; 95% CI -- 95% confidence interval; *NA*-- not available.

^\*^Pooled - Pooled Han Chinese without leprosy, which contained the reported samples from Hunan Province (N = 984), Shanghai (N = 1526)[@b27], and the Yuxi control samples in this study (Yuxi).

^\#^*P* values \< 0.05 were marked in bold and recalculated by using the unconditional logistic regression, with an adjustment for sex.
